AKBA short interest
Akebia Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 22,481,147 |
|---|---|
| Change vs prior report | 1,976,232 (+9.6%) |
| Change over six months | -14.4% |
| Days to cover | 3.51 (sector: 3.78) |
| Average daily volume | 6,412,381 |
| Rank in Healthcare | #585 of 922 by days to cover |
AKBA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 22,481,147 | +9.6% | 3.51 | 6,412,381 |
| 2026-09-15 | 20,504,915 | -10.9% | 2.76 | 7,439,437 |
| 2026-08-31 | 23,002,561 | +7.6% | 2.34 | 9,826,387 |
| 2026-08-14 | 21,371,566 | +11.4% | 3.54 | 6,044,103 |
| 2026-07-31 | 19,183,020 | +0.6% | 8.81 | 2,177,153 |
| 2026-07-15 | 19,076,806 | -0.5% | 4.20 | 4,543,375 |
| 2026-06-30 | 19,177,371 | -34.3% | 2.69 | 7,120,957 |
| 2026-06-15 | 29,201,925 | +6.5% | 5.60 | 5,214,571 |
| 2026-05-29 | 27,420,606 | +4.0% | 4.14 | 6,624,978 |
| 2026-05-15 | 26,371,163 | -4.5% | 5.69 | 4,638,423 |
| 2026-04-30 | 27,621,774 | +1.1% | 11.35 | 2,433,231 |
| 2026-04-15 | 27,313,287 | +4.0% | 13.48 | 2,026,908 |
| 2026-03-31 | 26,266,098 | -9.4% | 9.34 | 2,811,344 |
| 2026-03-13 | 28,988,090 | -2.4% | 10.34 | 2,804,123 |
| 2026-02-27 | 29,692,868 | -4.8% | 9.12 | 3,254,556 |
| 2026-02-13 | 31,207,330 | -15.5% | 7.10 | 4,396,546 |
| 2026-01-30 | 36,927,875 | -0.3% | 14.15 | 2,609,774 |
| 2026-01-15 | 37,025,281 | +2.7% | 11.09 | 3,337,924 |
| 2025-12-31 | 36,058,633 | +4.3% | 12.71 | 2,835,925 |
| 2025-12-15 | 34,581,801 | -3.7% | 10.32 | 3,351,672 |
| 2025-11-28 | 35,918,701 | +1.6% | 10.18 | 3,529,859 |
| 2025-11-14 | 35,344,201 | -0.5% | 5.47 | 6,462,599 |
| 2025-10-31 | 35,517,452 | +21.1% | 6.44 | 5,510,936 |
| 2025-10-15 | 29,319,644 | -0.3% | 10.91 | 2,687,857 |
| 2025-09-30 | 29,401,452 | +7.5% | 9.21 | 3,190,649 |
import finzdata as yf
yf.Ticker("AKBA").short_interest # every report since 2017
yf.Client().short_interest(["AKBA"], start="2018-01-01")Healthcare short interest · AKBA price history · Who owns AKBA · All short interest